HLF
HerbalifeBNYSE / Household & Personal Products
Last Price
At close
2026-07-20
Current thesis
The bull case is that Q1 2026 came in above guidance, full-year midpoint guidance was raised, refinancing should lower interest burden, and Bioniq adds another growth lever if rollout and distributor adoption scale.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Bioniq adoption and rollout execution are early-stage and could disappoint.
Momentum
31
Value
73
Sentiment
66
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $15.50 · Bull $19.00 · Bear $10.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-19 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $18.33
Why
Momentum31 · Δ7d +5.8
Value73 · Δ7d +0.1
Sentiment66 · Δ7d +6.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
31
26% active weight
Current posture
7d trendFlat
Δ7d
+5.8
Δ21d
+16.9
Value
73
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.9
Sentiment
66
34% active weight
Current posture
7d trendImproving
Δ7d
+6.3
Δ21d
+3.4
Why this grade
Composite grade B. Momentum 31.2 / Value 72.6 / Sentiment 66.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.27B
Beta
0.84
Shares Out
103.67M
P/E (TTM)
4.1
P/S (TTM)
0.27
P/FCF (TTM)
6.15
Rev YoY
+7.8%
EPS YoY
+15.8%
Gross Margin
+75.2%
Op Margin
+9.8%
Net Debt
$1.83B
Current Ratio
1.23
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology